The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Massimo Cristofanilli

Department of Breast Medical Oncology

The University of Texas M.D. Anderson Cancer Center

Houston

Texas 77030-1439

USA

[email]@mdanderson.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-1439, USA. 2002 - 2010

References

  1. Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer. Cristofanilli, M., Valero, V., Mangalik, A., Royce, M., Rabinowitz, I., Arena, F.P., Kroener, J.F., Curcio, E., Watkins, C., Bacus, S., Cora, E.M., Anderson, E., Magill, P.J. Clin. Cancer Res. (2010) [Pubmed]
  2. Novel targeted therapies in inflammatory breast cancer. Cristofanilli, M. Cancer (2010) [Pubmed]
  3. The biological information obtainable from circulating tumor cells. Cristofanilli, M. Breast (2009) [Pubmed]
  4. Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations. Cristofanilli, M., Morandi, P., Krishnamurthy, S., Reuben, J.M., Lee, B.N., Francis, D., Booser, D.J., Green, M.C., Arun, B.K., Pusztai, L., Lopez, A., Islam, R., Valero, V., Hortobagyi, G.N. Ann. Oncol. (2008) [Pubmed]
  5. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease. Cristofanilli, M., Valero, V., Buzdar, A.U., Kau, S.W., Broglio, K.R., Gonzalez-Angulo, A.M., Sneige, N., Islam, R., Ueno, N.T., Buchholz, T.A., Singletary, S.E., Hortobagyi, G.N. Cancer (2007) [Pubmed]
  6. Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Cristofanilli, M., Broglio, K.R., Guarneri, V., Jackson, S., Fritsche, H.A., Islam, R., Dawood, S., Reuben, J.M., Kau, S.W., Lara, J.M., Krishnamurthy, S., Ueno, N.T., Hortobagyi, G.N., Valero, V. Clin. Breast Cancer (2007) [Pubmed]
  7. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Cristofanilli, M. Semin. Oncol. (2006) [Pubmed]
  8. A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approach. Cristofanilli, M., Krishnamurthy, S., Guerra, L., Broglio, K., Arun, B., Booser, D.J., Menander, K., Van Wart Hood, J., Valero, V., Hortobagyi, G.N. Cancer (2006) [Pubmed]
  9. Circulating tumor cells in breast cancer: Advanced tools for "tailored" therapy?. Cristofanilli, M., Mendelsohn, J. Proc. Natl. Acad. Sci. U.S.A. (2006) [Pubmed]
  10. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. Cristofanilli, M., Gonzalez-Angulo, A., Sneige, N., Kau, S.W., Broglio, K., Theriault, R.L., Valero, V., Buzdar, A.U., Kuerer, H., Buccholz, T.A., Hortobagyi, G.N. J. Clin. Oncol. (2005) [Pubmed]
  11. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cristofanilli, M., Yamamura, Y., Kau, S.W., Bevers, T., Strom, S., Patangan, M., Hsu, L., Krishnamurthy, S., Theriault, R.L., Hortobagyi, G.N. Cancer (2005) [Pubmed]
  12. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. Cristofanilli, M., Hayes, D.F., Budd, G.T., Ellis, M.J., Stopeck, A., Reuben, J.M., Doyle, G.V., Matera, J., Allard, W.J., Miller, M.C., Fritsche, H.A., Hortobagyi, G.N., Terstappen, L.W. J. Clin. Oncol. (2005) [Pubmed]
  13. Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience. Cristofanilli, M., Gonzalez-Angulo, A.M., Buzdar, A.U., Kau, S.W., Frye, D.K., Hortobagyi, G.N. Clin. Breast Cancer (2004) [Pubmed]
  14. Breast cancer highlights: key findings from the San Antonio Breast Cancer Symposium: a U.S. perspective. Cristofanilli, M., Hortobágyi, G.N. Oncologist (2004) [Pubmed]
  15. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Cristofanilli, M., Budd, G.T., Ellis, M.J., Stopeck, A., Matera, J., Miller, M.C., Reuben, J.M., Doyle, G.V., Allard, W.J., Terstappen, L.W., Hayes, D.F. N. Engl. J. Med. (2004) [Pubmed]
  16. Update on the management of inflammatory breast cancer. Cristofanilli, M., Buzdar, A.U., Hortobágyi, G.N. Oncologist (2003) [Pubmed]
  17. Angiogenesis modulation in cancer research: novel clinical approaches. Cristofanilli, M., Charnsangavej, C., Hortobagyi, G.N. Nat. Rev. Drug. Discov (2002) [Pubmed]
 
WikiGenes - Universities